Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction

被引:27
|
作者
Weiss, Andreas [1 ]
Roscic, Ana [1 ]
Paganetti, Paolo [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci Discovery, Basel, Switzerland
关键词
WILD-TYPE; IN-VIVO; TERMINAL FRAGMENTS; GENE-EXPRESSION; TRANSGENIC MICE; COMPLEX-II; DEATH; APOPTOSIS; ACONITASE; LENGTH;
D O I
10.1186/1750-1326-4-11
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Expansion of a polyglutamine repeat at the amino-terminus of huntingtin is the probable cause for Huntington's disease, a lethal progressive autosomal-dominant neurodegenerative disorders characterized by impaired motor performance and severe brain atrophy. The expanded polyglutamine repeat changes the conformation of huntingtin and initiates a range of pathogenic mechanisms in neurons including intracellular huntingtin aggregates, transcriptional dysregulation, energy metabolism deficits, synaptic dystrophy and ultimately neurodegeneration. It is unclear how these events relate to each other or if they can be reversed by pharmacological intervention. Here, we describe neuronal cell lines expressing inducible fragments of normal and mutant huntingtin. Results: In HN10 cells, the expression of wild type and mutant huntingtin fragments was dependent on the induction time as well as on the concentration of the RheoSwitch (R) inducing ligand. In order to analyze the effect of mutant huntingtin expression on cellular functions we concentrated on the 72Q exon1 huntingtin expressing cell line and found that upon induction, it was possible to carefully dissect mutant huntingtin-induced phenotypes as they developed over time. Dysregulation of transcription as a result of mutant huntingtin expression showed a transcription signature replicating that reported in animal models and Huntington's disease patients. Crucially, triggering of neuronal differentiation in mutant huntingtin expressing cell resulted in the appearance of additional pathological hallmarks of Huntington's disease including cell death. Conclusion: We developed neuronal cell lines with inducible expression of wild type and mutant huntingtin. These new cell lines represent a reliable in vitro system for modeling Huntington's disease and should find wide use for high-throughput screening application and for investigating the biology of mutant huntingtin.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction
    Andreas Weiss
    Ana Roscic
    Paolo Paganetti
    Molecular Neurodegeneration, 4
  • [2] Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice
    Petkau, Terri L.
    Hill, Austin
    Connolly, Colum
    Lu, Ge
    Wagner, Pam
    Kosior, Natalia
    Blanco, Jake
    Leavitt, Blair R.
    HUMAN MOLECULAR GENETICS, 2019, 28 (10) : 1661 - 1670
  • [3] Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
    Wang, Nan
    Gray, Michelle
    Lu, Xiao-Hong
    Cantle, Jeffrey P.
    Holley, Sandra M.
    Greiner, Erin
    Gu, Xiaofeng
    Shirasaki, Dyna
    Cepeda, Carlos
    Li, Yuqing
    Dong, Hongwei
    Levine, Michael S.
    Yang, X. William
    NATURE MEDICINE, 2014, 20 (05) : 540 - 545
  • [4] Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
    Nan Wang
    Michelle Gray
    Xiao-Hong Lu
    Jeffrey P Cantle
    Sandra M Holley
    Erin Greiner
    Xiaofeng Gu
    Dyna Shirasaki
    Carlos Cepeda
    Yuqing Li
    Hongwei Dong
    Michael S Levine
    X William Yang
    Nature Medicine, 2014, 20 : 536 - 541
  • [5] Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice
    Schilling, G
    Savonenko, AV
    Klevytska, A
    Morton, JL
    Tucker, SM
    Poirier, M
    Gale, A
    Chan, N
    Gonzales, V
    Slunt, HH
    Coonfield, ML
    Jenkins, NA
    Copeland, NG
    Ross, CA
    Borchelt, DR
    HUMAN MOLECULAR GENETICS, 2004, 13 (15) : 1599 - 1610
  • [6] Analysis of mutant and total huntingtin expression in Huntington's disease murine models
    Fodale, Valentina
    Pintauro, Roberta
    Daldin, Manuel
    Altobelli, Roberta
    Spiezia, Maria Carolina
    Bisbocci, Monica
    Macdonald, Douglas
    Bresciani, Alberto
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [7] Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
    Valentina Fodale
    Roberta Pintauro
    Manuel Daldin
    Roberta Altobelli
    Maria Carolina Spiezia
    Monica Bisbocci
    Douglas Macdonald
    Alberto Bresciani
    Scientific Reports, 10
  • [8] Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration
    Cicchetti, F.
    Saporta, S.
    Hauser, R. A.
    Parent, M.
    Saint-Pierre, M.
    Sanberg, P. R.
    Li, X. J.
    Parker, J. R.
    Chu, Y.
    Mufson, E. J.
    Kordower, J. H.
    Freeman, T. B.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (30) : 12483 - 12488
  • [9] Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
    Weiss, Andreas
    Traeger, Ulrike
    Wild, Edward J.
    Grueninger, Stephan
    Farmer, Ruth
    Landles, Christian
    Scahil, Rachael I.
    Lahiri, Nayana
    Haider, Salman
    Macdonald, Douglas
    Frost, Chris
    Bates, Gillian P.
    Bilbe, Graeme
    Kuhn, Rainer
    Andre, Ralph
    Tabrizi, Sarah J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (10): : 3731 - 3736
  • [10] Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
    Wild, E. J.
    Weiss, A.
    Trager, U.
    Grueninger, S.
    Farmer, R.
    Landles, C.
    Scahill, R.
    Lahiri, N.
    Haider, S.
    Macdonald, D.
    Frost, C.
    Bates, G.
    Bilbe, G.
    Kuhn, R.
    Andre, R.
    Tabrizi, S.
    MOVEMENT DISORDERS, 2013, 28 : S268 - S269